tolazamide has been researched along with Central Nervous System Origin Vertigo in 2 studies
Tolazamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE.
tolazamide : An N-sulfonylurea that is 1-tosylurea in which a hydrogen attached to the nitrogen at position 3 is replaced by an azepan-1-yl group. A hypoglycemic agent, it is used for the treatment of type 2 diabetes mellitus.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Düntsch, G | 2 |
2 other studies available for tolazamide and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
[Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions].
Topics: Ambulatory Care; Blood Glucose; Cholesterol; Depression, Chemical; Diabetes Mellitus; Female; Humans | 1970 |
[Results of oral therapy of diabetes mellitus with the new sulfonylurea tolazamide under ambulatory conditions].
Topics: Ambulatory Care; Blood Glucose; Cholesterol; Depression, Chemical; Diabetes Mellitus; Female; Humans | 1970 |